What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial.
about
Screening for breast cancer with mammographyScreening for breast cancer with mammographyScreening for breast cancer with mammographyScreening for breast cancer with mammographyMammographic screening and mammographic patterns.Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.The relationship between age and incidence of breast cancer. Population and screening program data.Cancer screening in older adults.The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.Time interval since last test in a breast cancer screening programme: a case-control study in Italy.Breast cancer early diagnosis experience in Florence: can a self referral policy achieve the results of service screening?Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.Cancer screening trials: nuts and bolts.Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 yearsIs there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality.The rationale and current controversies of mammographic screening for breast cancer.Mammography screening in African American women: evaluating the research.National Health Service breast screening programme results for 1991-2.Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group.Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden.A study of interval breast cancer within the NHS breast screening programmeEffects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40-49 in Finland.Biologic variations of tumors.Periodic breast cancer screening in seven foreign countries.Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-upThe South Australian Breast X-Ray Service: results from a statewide mammographic screening programme.Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.Prevention in family practice: Consensus statement from the front line.The occurrence of interval cancers in the Nijmegen screening programme.Breast cancer screening programmes: the development of a monitoring and evaluation system.The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases.Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia.Interval cancers in the Dutch breast cancer screening programme.A comparative audit of prevalent, incident and interval cancers in the Avon breast screening programme.Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening.Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.Early detection of breast cancer: mammography.Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.
P2860
Q24202273-4B67EEBA-C1C3-48CE-89AC-00551BCDD18EQ24234793-BE913EA0-DD03-4870-BD91-B5FB6AFBA599Q24240411-6BDE6A6E-A5F3-4A25-A0CF-584EE117E243Q24244332-55879F07-6669-4975-9D74-96D7E3F3FA8DQ24803203-B4D1EFEE-0640-4A40-A3AB-CF509F1030D8Q27347760-373129AE-D8AB-4E72-8E42-316468430962Q30965467-9DA54430-5EBD-4E84-887E-F378CDA9D402Q33560219-41C533AD-C66E-4491-863D-24200F142EBCQ33687150-80940640-9E31-4C2A-982B-A29928B88143Q33687280-7CE308BF-1C2E-4324-8F42-E1554D66D77EQ33702632-65BDEA66-25E5-432C-8C38-54B3E5A624A3Q33703341-719D3673-EEA1-4A11-ACB7-08D73E8FE3CEQ34073143-926AABD1-BB07-4831-9701-B9753DD3B6C9Q34275673-4D51218D-6465-4965-810F-973DE58730F7Q34492408-85113591-F99F-4850-955D-5D97CF06CC28Q35008192-AA5CA6A9-392A-4810-BC02-10B6204B678AQ35030256-DC395A01-32A5-4E4D-9C81-88D47117D1B7Q35188788-7B6A44ED-DC55-4442-BDCF-524CEFD23379Q35558150-86DF4823-9C95-4093-8F35-35493242BDD6Q35558319-ED45F010-BA25-4C1F-9600-A6857F987959Q35571833-B9CE1896-9E5C-49A5-8F2E-3B7009EB2583Q35620645-E87085B6-7C89-4056-BC50-5221BCA57BB8Q35900833-B01D0886-EBE7-40C1-BB58-592C34CBF1E3Q35900844-5C8393CD-9C7C-48CF-8365-ED41E98719A8Q35990552-F4BB190C-6DBA-489A-BC77-ED3901AB9824Q36079546-014FA19F-C6E4-4995-9477-F3F9D902B8F1Q36134741-9C09A15D-8672-4908-B700-27E9631B5607Q36277707-57E8FED0-5C3A-4120-A165-6278BFE4913BQ36283924-7A6ADE72-9538-4438-81B2-6F611235216EQ36466514-EE03488D-7997-4066-BAA9-3BF575732E6CQ36466539-5D4538F6-EF95-453F-A99A-F9981F0822ABQ36467778-DB4D9A2A-DECC-4EB0-A5DC-A340F6DE2E6FQ36622525-8C33F4E4-D193-4D40-A494-1C9D02D3C55FQ36640969-551AAFE6-0B86-4807-95AE-E8813F30478CQ36821390-025C3180-D260-4B5D-AEDA-CA6E7032EEEBQ36902072-AA08087E-2FDF-412D-BC87-3682CDE5E0EAQ36905384-4CD8604E-24D6-4815-90D3-0D55E3597E1AQ36930872-A8B28ADA-0DCF-4DA0-BEF5-A04557E08EB6Q37253410-16DEC999-7226-4AB6-A3E9-54CB79C8269BQ37279014-9A235455-3E25-473B-9025-626FB4A6BBF1
P2860
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
What is the optimum interval b ...... breast cancer screening trial.
@ast
What is the optimum interval b ...... breast cancer screening trial.
@en
type
label
What is the optimum interval b ...... breast cancer screening trial.
@ast
What is the optimum interval b ...... breast cancer screening trial.
@en
prefLabel
What is the optimum interval b ...... breast cancer screening trial.
@ast
What is the optimum interval b ...... breast cancer screening trial.
@en
P2093
P2860
P356
P1476
What is the optimum interval b ...... breast cancer screening trial.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1987.112
P407
P577
1987-05-01T00:00:00Z